
CCZ · Nasdaq
CCZ is a Comcast Holdings security, not Comcast Corporation common stock: supplied listings identify it as 2% exchangeable subordinated debentures expiring November 15, 2029. The evidence does not describe Comcast’s products, operating segments, customer base, or segment revenue mix, so those details cannot be stated reliably here. The supplied financials report FY2025 revenue of $123.7 billion and net income of $20.0 billion, compared with FY2024 revenue of $123.7 billion and net income of $16.2 billion. These figures indicate the issuer’s reported scale, but do not show the operating composition behind it. The security represents debt exposure with exchange features, not an operating-company share.
CCZ lost 0.92%, from $65.10 on October 22 to $64.50 on October 29. The daily tape shows that the sharpest drop came on October 23, before the stated week began, when the close fell to $62.30. During the October 26–29 period, the stock closed at $62.55 on Monday, Tuesday, and Wednesday, then rebounded to $64.50 on Thursday, a $1.95 gain on volume of 2,120. Thus, the stated week-end price masks a late-week recovery from the lower daily closes. The supplied evidence contains no company-specific catalyst or broader market data to explain the trading.
CCZ rose 0.77%, from $65.00 to $65.50, over the stated week. The daily closes show an early dip to $64.82 on October 13, followed by a jump to $65.70 on October 14; shares then held at that level through October 16 before easing to $65.50 on October 19, giving back 20 cents of the midweek rise. Trading was thin: reported volume was 781 and 701 shares on October 12 and 13, then 100 shares on October 14 and October 19. The evidence identifies no company-specific news or broader market driver for the move, and the supplied data point instead to limited trading activity rather than a news-driven repricing.
CCZ gained $2.10, or 3.34%, over the reported period, moving from $62.90 to $65.00. The displayed closes were unchanged at $62.90 on each session from October 5 through October 9, before the entire recorded advance appeared on Monday, October 12. That session closed at $65.00 on volume of 781; there is no earlier in-week rise to describe as having reversed. The supplied evidence identifies no company announcement, analyst action, or other company-specific catalyst for the jump, and it provides no market benchmark or sector data with which to explain the move externally. The gain therefore remains unattributed on the available evidence.
CCZ fell $1.77, or 2.74%, from $64.67 to $62.90 over the reported week. The decline occurred in one step: the close dropped from $64.67 on September 29 to $62.90 on September 30, when reported volume was 229 shares. It then closed at $62.90 on each reported session through October 6, with no subsequent recovery or further decline. The supplied evidence identifies no company-specific announcement or catalyst for the move, and provides no broad-market benchmark to explain it in context. The available price record therefore shows a sharp single-session drop followed by unchanged closes, but does not establish what drove the selling.
CCZ fell 2.74%, from $64.67 to $62.90, over the week beginning September 28. The close stayed at $64.67 on September 28 and 29, matching the prior two trading days, before dropping $1.77 on September 30; it then held at $62.90 on October 1. Reported volume on the down day was 229. The supplied evidence identifies no company-specific announcement or event to explain the repricing, and it provides no market benchmark or broader-market news with which to attribute the move to sector or market conditions. The week’s decline was therefore concentrated in one session, with no recovery in the final reported close.
CCZ finished the observed week unchanged at $64.67 (0.00%), with every supplied close from September 16 through September 23 fixed at $64.67. There was no within-week advance or reversal. The supplied evidence identifies no company-specific announcement or dated analyst action tied to CCZ during this period; the reported Comcast downgrade concerns Comcast common stock, not CCZ, and is dated September 25, after the final supplied close. No market-index or sector performance is provided to explain the unchanged price. Thus, the available record supports a flat week without an attributable catalyst.
CCZ fell $1.78, or 2.68%, from $66.45 to $64.67 over the reported week. Trading was unchanged at $66.45 through September 4, before the stock dropped on September 8 on volume of 103. The supplied evidence identifies no company-specific announcement, earnings update, contract, guidance change, analyst action, or other catalyst explaining the decline. It also provides no broader market, sector, interest-rate, or macroeconomic explanation for the move. Accordingly, the week's performance is best characterized as a late-period decline without an identified fundamental driver, rather than a sequence of materially documented reversals.
CCZ was unchanged at $66.45 over the week, a $0.00 move, with every reported close from August 31 through September 3 remaining identical. The supplied evidence does not identify a company-specific catalyst that affected trading during the period. Two Stock Titan items concern Comcast executive securities activity: a co-CEO exiting deferred stock units and the chair gifting 101,900 shares while disposing of 382,860 restricted stock units, but neither snippet provides a date tied to this week or evidence of a market reaction. No broader market or sector performance data is supplied, so the flat result cannot be attributed to market context.
CCZ was unchanged over the week, ending at $66.45 versus $66.45 at the prior Friday close, a $0.00 move (0.00%). Every reported daily close from Monday through Friday was $66.45, so there was no within-week reversal or measurable momentum to explain. The supplied evidence contains no dated company announcement, earnings release, contract, target change, or rating action tied to August 24–28. It therefore does not identify a company-specific catalyst for the lack of movement. The available external items are generic quote, chart, insider, and ratings pages, while the technical-analysis snippet concerns June 3 rather than this week.
CCZ fell $1.99, or 3.02%, from $65.99 to $64.00 across the supplied Aug. 3–10 window. The decline was concentrated on Aug. 5, when the stock dropped to $64.30 on volume of 1,514, followed by a further 30-cent decline on Aug. 6 on volume of 421. It then held at $64.00 through Aug. 10, with no material reversal. The supplied evidence does not identify a company-specific catalyst explaining the move. A Capital World Investors beneficial-ownership report and an Aug. 10 Comcast SEC-filing headline appeared in the period, but no snippet links either to the price decline. Trading was thin, and broader market drivers are not provided.
CCZ was unchanged, finishing the observed week at $65.99, a $0.00 move or 0.00%. Every listed close from July 28 through August 4 was exactly $65.99, so there was no material intraday reversal or change in trading direction to explain. The supplied evidence contains no company-specific announcement, earnings release, contract, guidance update, analyst action, or other catalyst during the week. It also provides no market-performance context that could explain the inactivity. The available technical-analysis snippet concerns June 3 rather than this week and therefore does not explain the unchanged August price. Overall, CCZ moved without an identifiable company or market driver in the supplied record.